Iatrogenic Kaposi’s sarcoma from induction therapy for myeloma: to transplant or not to transplant?

We present the case of an HIV-negative man in his 50s who developed a generalised nodular rash while having first-line bortezomib–cyclophosphamide–dexamethasone chemotherapy for multiple myeloma. The rash was biopsied and proven to be Kaposi’s sarcoma. The patient’s treatment was interrupted at the...

Descripción completa

Detalles Bibliográficos
Autores principales: Farrugia, Daniel, Sultana, Erika, Babic, Darko, Grech, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Case Reports: Adverse drug reactions and complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255255/
https://www.ncbi.nlm.nih.gov/pubmed/37263679
http://dx.doi.org/10.1136/bcr-2022-251044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255255/
https://www.ncbi.nlm.nih.gov/pubmed/37263679
http://dx.doi.org/10.1136/bcr-2022-251044

Ejemplares similares